Literature DB >> 21835430

Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders.

Luisa Lorenzi1, Silvia Lonardi, Giulia Petrilli, Francesco Tanda, Michelangelo Bella, Licia Laurino, Giuseppe Rossi, Fabio Facchetti.   

Abstract

We report three cases of follicular dendritic cell sarcoma (FDCS) showing a hitherto undescribed histological pattern consisting of nodular tumor growth associated with small B lymphocytes. FDCS tumor cells consistently showed large epithelioid features and were intermingled with small lymphocytes in the nodules in two cases, whereas they formed cohesive aggregates surrounded by lymphocyte mantle in the other. These features were easily confused with lymphomatous proliferations and, in particular, subtypes of Hodgkin lymphoma, high-grade follicular lymphoma, and germinotropic large B-cell lymphomas. The diagnosis was established by the use of a broad panel of antibodies that showed a variable expression of the FDC markers CD21, CD23, CD35, clusterin, podoplanin, claudin 4, epidermal growth factor receptor, and CXCL13. The associated B lymphocytes revealed a mantle zone B phenotype, with expression of CD20 and PAX5, together with TCL1 and IgD. Of notice, in all cases, morphological features suggesting hyaline-vascular Castleman disease were recognized in the interfollicular areas, containing scattered epithelioid cells similar to those found in the nodules, thus providing a useful clue for FDCS diagnosis. Of the 3 cases, 1 presented multiple recurrences unresponsive to chemotherapy and radiotherapy and finally died of disease 14 years after diagnosis. This study further emphasizes the extreme variability of morphological presentation of FDCS and expands the spectrum of lesions showing a nodular growth pattern occurring in human lymph nodes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835430     DOI: 10.1016/j.humpath.2011.02.029

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.

Authors:  Fabio Facchetti; Stefano Aldo Pileri; Luisa Lorenzi; Valentina Tabanelli; Lisa Rimsza; Stefania Pittaluga; Stephan Dirnhofer; Christiane Copie-Bergman; Laurence de Leval; Andreas Rosenwald; Andrew Wotherspoon; Falko Fend
Journal:  Virchows Arch       Date:  2017-07-10       Impact factor: 4.064

2.  Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of "germinotropic" lymphoproliferative disorder.

Authors:  Luisa Lorenzi; Silvia Lonardi; Murad H M Essatari; Vilma Pellegrini; Simona Fisogni; Anna Gazzola; Claudio Agostinelli; William Vermi; Giuseppe Rossi; Giovannino Massarelli; Stefano A Pileri; Fabio Facchetti
Journal:  Virchows Arch       Date:  2016-01-13       Impact factor: 4.064

3.  Follicular dendritic cell sarcoma with atypical features surrounding undescended testis: description of a rare case.

Authors:  Alberto Testori; Stefano Meroni; Piergiuseppe Colombo; Stefano Fiori; Emanuele Voulaz; Marco Alloisio
Journal:  World J Surg Oncol       Date:  2015-02-21       Impact factor: 2.754

4.  Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing.

Authors:  Luisa Lorenzi; Claudia Döring; Tobias Rausch; Vladimir Benes; Silvia Lonardi; Mattia Bugatti; Elias Campo; José Cabeçadas; Ingrid Simonitsch-Klupp; Anita Borges; Jay Mehta; Claudio Agostinelli; Stefano Aldo Pileri; Fabio Facchetti; Martin-Leo Hansmann; Sylvia Hartmann
Journal:  Oncotarget       Date:  2017-03-07

Review 5.  Follicular dendritic cell sarcoma.

Authors:  Fabio Facchetti; Matteo Simbeni; Luisa Lorenzi
Journal:  Pathologica       Date:  2021-10

Review 6.  Histiocytic and dendritic cell neoplasms of the mediastinum.

Authors:  Ezra Baraban; Kumarasen Cooper
Journal:  Mediastinum       Date:  2020-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.